Cardiac tumors prevalence and mortality: A systematic review and meta-analysis. (April 2020)

• Record Type: Journal Article
• Authors: Rahouma, Mohamed; Arisha, Mohammed J.; Elmously, Adham; El-Sayed Ahmed, Magdy M.; Spadaccio, Cristiano; Mehta, Kritika; Baudo, Massimo; Kamel, Mohamed; Mansor, Esraa; Ruan, Yongle; Morsi, Mahmoud; Shmushkevich, Shon; Eldessouki, Ihab; Rahouma, Mostafa; Mohamed, Abdelrahamn; Gambardella, Ivancarmine; Girardi, Leonard; Gaudino, Mario
• Is Part Of: International journal of surgery. Volume 76(2020)
• Page Start: 178
• Page End: 189
• Publication Date: 2020-04
• Subjects: Cardiac tumors -- Heart transplantation -- Meta-regression; Surgery -- Periodicals; Surgical Procedures, Operative -- Periodicals; 617.005
• DOI: 10.1016/j.ijsu.2020.02.039
• Languages: English
• ISSNs: 1743-9191

Abstract

Abstract: Objectives: Cardiac tumors and their associated outcomes are poorly characterized. This study sought to comprehensively assess the epidemiology and natural history of primary and secondary malignant cardiac tumors (PMCT and SMCT), a well as establish predictors of mortality. Methods: A comprehensive literature review was performed to identify articles reporting on PMCTs and SMCTs. The prevalence of important cardiac tumor (CT) subtypes was evaluated and further stratified based on the continental region. Outcomes of interest included short- and long-term mortality and utilization of heart transplantation (HTX). A random effect model was adopted, and a meta-regression was performed to determine predictors of the prevalence of CTs as well as predictors of operative mortality. Results: Of the 1, 226 retrieved articles, 74 were included in our study (n = 8, 849 patients). The mean follow-up was 2.27 years, mean age was 42.9 years, and 55% of the patients were females. There was a total number of 7, 484 benign primary cardiac tumors (PCTs) (5, 140 were myxoma), 862 (9.7%) malignant PCTs, and 355 secondary cardiac tumors. The prevalence of PMCTs among PCTs was 10.83% [95%CI = 09.11; 12.83%] with a trend towards being lower in South America compared to other continents (Prevalence = 5.80%). The prevalence of HTX among all patients was 2.45% [1.36; 4.38%]. The pooled short-term mortality was 5.90% [4.70; 7.39%] and the incidence of late mortality in all CTs, benign CT and PMCTs was 2.55% [1.76; 3.72%], 0.79% [0.46; 1.37%] and 14.77% [9.32; 23.40%], respectively. On meta-regression, the annual volume of cardiac tumor cases per center was the only predictor of lower early mortality (Beta = −0.14 ± 0.03, P < 0.0001). Conclusions: PMCTs represent the minority of PCT (~10%) and have a higher prevalence in Europe and North America. Survival is higher in benign pathology and is significantly improved by treatment in specialized high-volume centers. Approximately 2% of patients with CTs undergo heart transplantation. Highlights: Prevalence of primary malignant cardiac tumors among primary cardiac tumors was 10.83%. Prevalence of heart transplantation among all CTs patients was 2.45%. Pooled short term mortality was 5.90% and late mortality in all CTs, benign CT and PMCTs was 2.55%, 0.79% and 14.77% respectively. Mortality rates for CT patients occur at a mean rate of 2.55% person per year. High volume centers are has less mortality.